The purpose of this research is to find out how people with epilepsy and possible symptoms of anxiety or depression are doing for 6 months after a regular epilepsy clinic visit. Participants in this study will complete questionnaires either by phone or via the patient portal.
This is a study among N=30 individuals with epilepsy and high or borderline anxiety or depression symptoms receiving usual care at the Wake Forest Comprehensive Epilepsy Center. Participants are randomized to one of two outcome assessment methods \[Electronic Medical Record (EMR)-based-interventional method vs. telephone-based-standard method\] for collecting quality of life, anxiety and depression outcomes at 3 and 6 months, under usual care management. The primary aim of the study is to assess feasibility of EMR-based outcome assessment by measuring 6-month retention.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
30
Questionnaire delivery method. Participants will complete standard care anxiety and depression screening and quality of life assessment directly into the patient entered section of the EMR, administered on arrival in the clinic.
Questionnaires delivered via phone. Participants will complete standard care anxiety and depression screening and quality of life assessment via phone. Standard delivery method.
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
Percentage of Participants Retained in the Study in the EMR Arm
Retention is defined as the percentage of participants in the study who complete the 6 month outcome instruments in the EMR
Time frame: 6 months
Percentage of Participants Retained in the Study in the Phone Arm
Retention is defined as the percentage of participants in the study who complete the 6 month outcome instruments via phone
Time frame: 6 months
Quality of Life in Epilepsy-10 (QOLIE-10)
QOLIE-10 is A brief questionnaire (10-items) to screen for quality of life in epilepsy. Total Score 0-100. Higher scores denotes worse outcomes.
Time frame: Baseline
Quality of Life in Epilepsy-10 (QOLIE-10)
QOLIE-10 is A brief questionnaire (10-items) to screen for quality of life in epilepsy. Total Score 0-100. Higher scores denotes worse outcomes.
Time frame: 3 Months
Quality of Life in Epilepsy-10 (QOLIE-10)
QOLIE-10 is A brief questionnaire (10-items) to screen for quality of life in epilepsy. Total Score 0-100. Higher scores denotes worse outcomes.
Time frame: 6 Months
Generalized Anxiety Disorder 7-item (GAD-7) Scale
Anxiety scale. Total Score 0-28. Higher scores denotes worse outcomes.
Time frame: Baseline
Generalized Anxiety Disorder 7-item (GAD-7) Scale
Anxiety scale. Total Score 0-28. Higher scores denotes worse outcomes.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 3 Months
Generalized Anxiety Disorder 7-item (GAD-7) Scale
Anxiety scale. Total Score 0-28. Higher scores denotes worse outcomes.
Time frame: 6 months
Neurological Disorders Depression Inventory (NDDI-E)
The NDDI-E is a 6-item questionnaire validated to screen for depression in people with epilepsy. Total Score 4-24. Higher scores denotes worse outcomes.
Time frame: Baseline
Neurological Disorders Depression Inventory (NDDI-E)
The NDDI-E is a 6-item questionnaire validated to screen for depression in people with epilepsy. Total Score 4-24. Higher scores denotes worse outcomes.
Time frame: 3 Months
Neurological Disorders Depression Inventory (NDDI-E)
The NDDI-E is a 6-item questionnaire validated to screen for depression in people with epilepsy. Total Score 4-24. Higher scores denotes worse outcomes.
Time frame: 6 Months